End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,682 MXN | +0.06% | -0.79% | +1.36% |
06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |